IDEAYA Biosciences (IDYA) had its price target raised by The Goldman Sachs Group, Inc. from $31.00 to $35.00. They now have a "neutral" rating on the stock.
IDEAYA Biosciences (IDYA) had its price target raised by Wells Fargo & Company from $44.00 to $48.00. They now have an "overweight" rating on the stock.
IDEAYA Biosciences (IDYA) had its price target raised by Wedbush from $52.00 to $58.00. They now have an "outperform" rating on the stock.
IDEAYA Biosciences (IDYA) had its price target raised by Guggenheim from $50.00 to $54.00. They now have a "buy" rating on the stock.
IDEAYA Biosciences (IDYA) had its "outperform" rating reaffirmed by Royal Bank Of Canada.